The “Lab to Impact: IP and Commercialization Series” is an educational program designed to empower Cornell researchers with the knowledge and tools necessary to collaborate with the Center for Technology Licensing (CTL) in transforming Cornell innovations into impactful solutions. Organized into four topic-focused modules, each section provides targeted insights essential for navigating the commercialization process. By combining the latest trends, expert knowledge, and successful case studies, this series aims to catalyze innovation and expand the reach of your research through commercialization of innovations. This program is brought to you by the Innovation Team within Research and Innovation unit and is organized by the Center for Technology Licensing (CTL).
Key Modules
Intellectual
Property
Gain a solid foundation in intellectual property, including IP law, the tech transfer process, and strategic development for specific innovative areas, complemented by relevant case studies.
Commercialization
& Venture
Learn the strategies necessary to advance innovations for the benefit of society and understand the considerations for creating and growing startups.
Healthcare
Roadmap
Provides strategic guidance for bringing healthcare innovations to market, focusing on commercialization strategies, regulatory considerations, and lessons from successful case studies in the healthcare sector.
Social Science
Roadmap
Explore the intersection of social science and innovation, covering topics that drive equitable and impactful technological advancements.
Previous LTI Sessions
Intellectual Property
IP Series: Navigating the IP Maze in AI Technologies
March 7, 2024
This virtual event focused on securing IP rights for AI-related technologies. We explored the deep ideas with Jason Novak, Partner at Norton Rose Fulbright, specializing in Precision Medicine and Digital Health, alongside Douglas Link, a Member at Cozen O’Connor. They provided invaluable insights into obtaining IP protection and navigating the patent landscape in the digital health and AI sectors.
Commercialization & Venture
IP Series 2: U.S. Regulatory Requirements for Gene-Edited Plants
October 26, 2023
During this hybrid event, we discussed:
- How USDA, FDA, and EPA work together to regulate gene edited plants and foods produced therefrom
- Strategic considerations for addressing USDA’s SECURE rule
- The EPA’s new rules for Plant Incorporated Protectants (PIPS) created by gene editing.
Social Science Roadmap
CTL IP Series 1: Understanding the Technology Transfer Process
September 27, 2023
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
Intellectual Property
CTL IP Series 5: IP Strategies for Protecting and Commercializing Biotech Inventions
June 21, 2023
This IP series provided an overview of Biotech IP and commercialization strategies rooted in patent prosecution. During this fifth series, Eric Bryant, Intellectual Property officer at CTL, was joined by Yvonne Shyntum, Partner at Pabst Patent Group.
Commercialization & Venture
CTL IP Series 4: From Invention Disclosures to Issued Patents: An Inventor Perspective
April 20, 2023
This panel session aims to provide clarity and guidance by exploring the process from the perspective of an active inventor, Robert F. Shepherd, Associate Professor at Cornell University. Paul Roman, Partner at Johnson, Marcou, Isaacs & Nix, LLC, also joined him to provide a couple of examples from Shepherd’s IP portfolio and share best practices for successful patent applications.
Healthcare Roadmap
CTL IP Series 3: Software & Copyright
February 9, 2023
For this third installment of the IP Series, learn about software inventions and the copyright and patent strategies to protect them. Our experts from Ryan, Mason & Lewis, LLP delved into the definitions and practical case studies of legal challenges and infringements as well as the impact of some cases on the sector (e.g., Alice Corp. Pty. Ltd. v. CLS Bank Int’l).
Intellectual Property
CTL IP Series 2: What Makes Patents Commercially Relevant?
November 9, 2022
For this second session of the IP Series, Lisa Placanica, Senior Managing Director, and Eric Bryant, IP Officer at the Center for Technology Licensing at Weill Cornell Medicine, took a deep dive into key elements researchers should consider when working with CTL on the prosecution of their patent applications which will help make their IP commercially relevant.
Intellectual Property
CTL IP Series 1: Understanding the Technology Transfer Process
September 15, 2022
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
Intellectual Property
CTL IP Series 3: Successful Patent Applications–It’s All in the Timing
April 20, 2022
During the third installment of the IP Series, experts in intellectual property discussed real-life examples of practical considerations in invention disclosure timing, including enablement, written description and the hazards of prior art in publishing scientific findings before patenting.
Intellectual Property
CTL IP Series 2: Why are diagnostic claims so hard to get (in the US)?
February 17, 2022
During this second IP series, Troutman Pepper and CTL executives addressed the challenges of protecting diagnostic innovations in the United States. This talk provided insights into the patent eligibility limitations in this field, the strategies to overcome them, and the important aspects to consider as an inventor when you disclose to the CTL office.
Intellectual Property
CTL IP Series 1 (Bis): Understanding the Technology Transfer Process
October 26, 2021
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
Intellectual Property
CTL IP Series 3: Software, Copyright, and Trademark
April 22, 2021
This IP series provided an overview of the different types of intellectual property (IP), updates on the latest changes in the IP landscape and impact on strategies for protecting Cornell IP. During this third series, Bill Pegg, Associate Director for IP at CTL was joined by two IP Attorneys at Ryan, Mason & Lewis, LLP.
Intellectual Property
CTL IP Series 2: What is Patent Eligible in the U.S.?
March 19, 2021
For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, presented an overview of patent eligible subject matter and provided some examples to illustrate issues related to patent eligibility.
Intellectual Property
CTL IP Series 1: Understanding the Technology Transfer Process
February 19, 2021
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
Historical Learning Programs
IP Series
The series offered an overview of various types of intellectual property, highlighted recent updates in the IP landscape, and discussed their impact on strategies for protecting Cornell’s innovations.
New Venture Series
This series focused on a range of topics designed to support the formation and growth of technology startups.
WCM Special Panel
The CTL@WCM Special Panel hosted a series of webinars exploring the challenges and opportunities involved in bringing medical technologies from the bench to the bedside.
Social Science Innovation
This series offered an opportunity to explore how social science research can be transformed into impactful initiatives while guiding participants through the available Cornell resources and pathways for innovation.
